期刊文献+

Complications of radical nephrectomy for renal cell carcinoma: a retrospective study comparing transperitoneal and retroperitoneal approaches using a standardized reporting methodology in two Chinese centers 被引量:3

Complications of radical nephrectomy for renal cell carcinoma: a retrospective study comparing transperitoneal and retroperitoneal approaches using a standardized reporting methodology in two Chinese centers
下载PDF
导出
摘要 The reporting of complications following transperitoneal and retroperitoneal open radical nephrectomy (RN) is nonstandardized. This study aimed to compare early complications between the two approaches using a standardized reporting methodology in a large contemporary cohort. Between 1996 and 2009, 558 patients underwent open RN for renal cell carcinoma (RCC) in our two centers (424 from Sun Yat-sen University Cancer Center and 134 from the First Affiliated Hospital of Sun Yat-sen University). Records were reviewed for clinicopathologic features and complications. Complications were graded using the Clavien system based on the severity of impact. One hundred and five patients (18.8%) had one or more early complications (168 complications overall). The overall rates of grades I to V complications were 5.6%, 10.8%, 2.2%, 0.4%, and 0.2%, respectively. Patients who underwent transperitoneal RN did not experience more overall or procedure-related complications than those who underwent retroperitoneal RN (P=0.911 and P=0.851, respectively). On subgroup analysis, neither grade I/II nor grades III-V complications were significantly different between the transperitonal RN and retroperitoneal RN groups. Multivariate analysis showed that for any grade of complication, age (P=0.016) and estimated blood loss (P=0.001) were significant predictors. We concluded that open RN is a safe procedure associated with low rates of serious morbidity and mortality. Compared with retroperitoneal RN, transperitoneal RN was not associated with more complications. Older patient and more blood loss at surgery were independent predictors for higher early postoperative complication rates. The reporting of complications following transperitoneal and retroperitoneal open radical nephrectomy (RN) is nonstandardized. This study aimed to compare early complications between the two approaches using a standardized reporting methodology in a large contemporary cohort. Between 1996 and 2009, 558 patients underwent open RN for renal cell carcinoma (RCC) in our two centers (424 from Sun Yat-sen University Cancer Center and 134 from the First Affiliated Hospital of Sun Yat-sen University). Records were reviewed for clinicopathologic features and complications. Complications were graded using the Clavien system based on the severity of impact. One hundred and five patients (18.8%) had one or more early complications (168 complications overall). The overall rates of grades I to V complications were 5.6%, 10.8%, 2.2%, 0.4%, and 0.2%, respectively. Patients who underwent transperitoneal RN did not experience more overall or procedure-related complications than those who underwent retroperitoneal RN (P=0.911 and P=0.851, respectively). On subgroup analysis, neither grade I/II nor grades III-V complications were significantly different between the transperitonal RN and retroperitoneal RN groups. Multivariate analysis showed that for any grade of complication, age (P=0.016) and estimated blood loss (P=0.001) were significant predictors. We concluded that open RN is a safe procedure associated with low rates of serious morbidity and mortality. Compared with retroperitoneal RN, transperitoneal RN was not associated with more complications. Older patient and more blood loss at surgery were independent predictors for higher early postoperative complication rates.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2013年第8期461-468,共8页
关键词 并发症 肾细胞 切除术 标准化 腹膜 癌症 中国 中山大学 Radical nephrectomy complication standardized reporting methodology
  • 相关文献

参考文献32

  • 1Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin, 1999,49:8-31, 31.
  • 2Pantuck A J, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol, 2001,166:1611-1623.
  • 3Filson CP, Banerjee M, Wolf JS Jr, et al. Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy. J Urol, 2011,185:2072-2077.
  • 4Cooperberg MR, Mallin K, Kane C J, et al. Treatment trends for stage I renal cell carcinoma. J Urol, 2011,186:394-399.
  • 5Kim SP, Shah ND, Weight CJ, et al. Contemporary trends in nephrectomy for renal cell carcinoma in the united states: results from a population based cohort. J Urol, 2011,186:1779-1785.
  • 6Stephenson A J, Hakimi AA, Snyder ME, et al. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol, 2004,171:130-134.
  • 7Shekarriz B, Upadhyay J, Shekarriz H, et al. Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology, 2002,59:211-215.
  • 8Joudi FN, Allareddy V, Kane C J, et al. Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. J Urol, 2007,177:1709-1714.
  • 9Shuford MD, McDougall EM, Chang SS, et al. Complications of contemporary radical nephrectomy: comparison of open vs. laparoscopic approach. Urol Oncol, 2004,22:121-126.
  • 10Mejean A, Vogt B, Quazza JE, et al. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. Eur Urol, 1999,36:298-302.

同被引文献14

  • 1齐隽,虞永江,康健,张良,白强,孔良,王伟明,陈建华,刘建河,朱英坚,黄云腾,盛旭俊,沈海波,叶敏,陈方.淋巴结清扫在肾癌根治术中的意义[J].上海医学,2007,30(3):176-178. 被引量:2
  • 2Seiji Matsumoto,Shinya Kimura,Hidekazu Segawa,Junya Kuroda,Takeshi Yuasa,Kiyoshi Sato,Masaki Nogawa,Fumihiro Tanaka,Taira Maekawa,Hiromi Wada.Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines[J].Lung Cancer.2004(1)
  • 3Andrej Skerjanec,James Berenson,Chyi Hung Hsu,Pierre Major,Wilson H. Miller,Christina Raveray,Horst Schran,John Seaman,Felix Waldmeier.The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function[J].The Journal of Clinical Pharmacology.2003(2)
  • 4Gregory R Mundy,Toshiyuki Yoneda,Toru Hiraga.Preclinical studies with zoledronic acid and other bisphosphonates: Impact on the bone microenvironment[J].Seminars in Oncology.2001
  • 5King AE,Umland Em.Ostenonecrosis of the jaw in patients receiving intravenous of oral bisphosphonates[].Pharmaeo Theapy.2008
  • 6Teresita Bellido,Lilian I. Plotkin.Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability[J].Bone.2010(1)
  • 7Mark A. Scheper,Ashraf Badros,Andrew R. Salama,Gary Warburton,Kevin J. Cullen,Dianna S. Weikel,Timothy F. Meiller.A novel bioassay model to determine clinically significant bisphosphonate levels[J].Supportive Care in Cancer.2009(12)
  • 8N Giuliani,M Pedrazzoni,G Negri,G Passeri,M Impicciatore,G Girasole.Bisphosphonates Stimulate Formation of Osteoblast Precursors and Mineralized Nodules in Murine and Human Bone Marrow Cultures In Vitro and Promote Early Osteoblastogenesis in Young and Aged Mice In Vivo[J].Bone.1998(5)
  • 9T Komori,H Yagi,S Nomura,A Yamaguchi,K Sasaki,K Deguchi,Y Shimizu,R.T Bronson,Y.-H Gao,M Inada,M Sato,R Okamoto,Y Kitamura,S Yoshiki,T Kishimoto.Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts[J].Cell.1997(5)
  • 10Patricia Ducy,Rui Zhang,Valérie Geoffroy,Amy L Ridall,Gérard Karsenty.Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation[J].Cell.1997(5)

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部